Abbott Laboratories vs ViewRay
Market value, revenue, profit, valuation and financial strength side by side, each from the company's own filings or market data, with its date.
In short
- Abbott Laboratories is the larger company by market value: $181.1 B against $4 M for ViewRay, 45277 times as much (market caps of Oct 30, 2026 for Abbott Laboratories and Jul 30, 2023 for ViewRay). ViewRay's value is the last on file, from Jul 30, 2023: no market-data feed is connected for its exchange yet.
- Abbott Laboratories had more revenue: $44.3 B in the year to December 2025 against $70 M for ViewRay in the year to December 2021.
- Abbott Laboratories made a net profit of $6.5 B, while ViewRay made a net loss of $110 M.
- Abbott Laboratories keeps more of each dollar of sales: a net margin of 14.7% against -157.1% for ViewRay.
- Abbott Laboratories employs more people: 115,000 against 267 at ViewRay. Each employee brings in about $385,461 of revenue at Abbott Laboratories and $262,172 at ViewRay.
Market value, the same start = 100
From Jan 2020: how each one's value moved, whatever its size.
Revenue by fiscal year
US$ billions, as reported in each year's annual results.
Side by side
| Measure | Abbott Laboratories ABT · #117 in the world | ViewRay VRAY |
|---|---|---|
| Profile | ||
| Country | 🇺🇸 USA | 🇺🇸 USA |
| Sector | Healthcare | Healthcare |
| Industry | Medical Devices | Medical Devices |
| Founded | 1888 | 2004 |
| Size | ||
| Market cap | $181.1 B | $4 M* |
| Revenue | $44.3 B | $70 M |
| Net income | $6.5 B▲ best | $-110 M |
| Employees | 115,000 | 267 |
| Valuation | ||
| P/E ratio | 38.5× | — |
| Price to sales | 3.8× | — |
| Price to book | 3.5× | — |
| Free cash flow yield | 4.1% | — |
| Profitability | ||
| Gross margin | 56.4% | — |
| Operating margin | 18.2% | — |
| Net margin | 14.7% | — |
| Return on equity | 13.1% | — |
| Return on invested capital | 11.2% | — |
| Growth | ||
| Revenue growth | 5.7% | — |
| Revenue growth, 3 years a year | 0.5% | — |
| Earnings per share growth | -51.3% | — |
| Financial strength | ||
| Debt to equity | 0.3× | — |
| Cash | ||
| Free cash flow margin | 16.7% | — |
| Shareholder returns | ||
| Dividend yield | 2.3% | — |
| Shareholder yield | 2.8% | — |
| Strength scores | ||
| Piotroski F-score | 6 of 9 | — |
| Altman Z-score zone | safe | — |
| Data as of | Market cap Oct 2026; ratios FY2025 | Market cap Jul 2023 |
▲ marks the better of the two where higher or lower is better; size and valuation multiples are marked for neither
Questions and answers#
Which is bigger, Abbott Laboratories or ViewRay?
Abbott Laboratories is the larger company by market value: $181.1 B against $4 M for ViewRay, 45277 times as much (market caps of Oct 30, 2026 for Abbott Laboratories and Jul 30, 2023 for ViewRay). ViewRay's value is the last on file, from Jul 30, 2023: no market-data feed is connected for its exchange yet.
Which makes more money, Abbott Laboratories or ViewRay?
Abbott Laboratories had more revenue: $44.3 B in the year to December 2025 against $70 M for ViewRay in the year to December 2021. Abbott Laboratories made a net profit of $6.5 B, while ViewRay made a net loss of $110 M.
Which is more profitable, Abbott Laboratories or ViewRay?
Abbott Laboratories keeps more of each dollar of sales: a net margin of 14.7% against -157.1% for ViewRay.
Which has more employees, Abbott Laboratories or ViewRay?
Abbott Laboratories employs more people: 115,000 against 267 at ViewRay. Each employee brings in about $385,461 of revenue at Abbott Laboratories and $262,172 at ViewRay.
More about Abbott Laboratories
More about ViewRay
Sources#
Every figure on this page comes from these, with the date shown next to it.